Article

The metabotropic P2Y4 receptor participates in the commitment to differentiation and cell death of human neuroblastoma SH-SY5Y cells.

Fondazione Santa Lucia, Neurobiology Unit, Rome, Italy.
Neurobiology of Disease (impact factor: 5.4). 03/2005; 18(1):100-9. DOI:10.1016/j.nbd.2004.09.001 pp.100-9
Source: PubMed

ABSTRACT Extracellular nucleotides exert a variety of biological actions through different subtypes of P2 receptors. Here we characterized in the human neuroblastoma SH-SY5Y cells the simultaneous presence of various P2 receptors, belonging to the P2X ionotropic and P2Y metabotropic families. Western blot analysis detected the P2X1,2,4,5,6,7 and P2Y1,2,4,6, but not the P2X3 and P2Y12 receptors. We then investigated which biological effects were mediated by the P2Y4 subtype and its physiological pyrimidine agonist UTP. We found that neuronal differentiation of the SH-SY5Y cells with dibutiryl-cAMP increased the expression of the P2Y4 protein and that UTP itself was able to positively interfere with neuritogenesis. Moreover, transient transfection and activation of P2Y4 also facilitated neuritogenesis in SH-SY5Y cells, as detected by morphological phase contrast analysis and confocal examination of neurofilament proteins NFL. This was concurrent with increased transcription of immediate-early genes linked to differentiation such as cdk-5 and NeuroD6, and activity of AP-1 transcription family members such as c-fos, fos-B, and jun-D. Nevertheless, a prolonged activation of the P2Y4 receptor by UTP also induced cell death, both in naive, differentiated, and P2Y4-transfected SH-SY5Y cells, as measured by direct count of intact nuclei and cytofluorimetric analysis of damaged DNA. Taken together, our data indicate that the high expression and activation of the P2Y4 receptor participates in the neuronal differentiation and commitment to death of SH-SY5Y cells.

0 0
 · 
0 Bookmarks
 · 
18 Views
  • Source
    Article: Use of phosphatide precursors to promote synaptogenesis.
    [show abstract] [hide abstract]
    ABSTRACT: New brain synapses form when a postsynaptic structure, the dendritic spine, interacts with a presynaptic terminal. Brain synapses and dendritic spines, membrane-rich structures, are depleted in Alzheimer's disease, as are some circulating compounds needed for synthesizing phosphatides, the major constituents of synaptic membranes. Animals given three of these compounds, all nutrients-uridine, the omega-3 polyunsaturated fatty acid docosahexaenoic acid, and choline-develop increased levels of brain phosphatides and of proteins that are concentrated within synaptic membranes (e.g., PSD-95, synapsin-1), improved cognition, and enhanced neurotransmitter release. The nutrients work by increasing the substrate-saturation of low-affinity enzymes that synthesize the phosphatides. Moreover, uridine and its nucleotide metabolites activate brain P2Y receptors, which control neuronal differentiation and synaptic protein synthesis. A preparation containing these compounds is being tested for treating Alzheimer's disease.
    Annual Review of Nutrition 05/2009; 29:59-87. · 9.45 Impact Factor

Keywords

AP-1 transcription family members
 
biological effects
 
cytofluorimetric analysis
 
differentiated
 
Extracellular nucleotides
 
human neuroblastoma SH-SY5Y cells
 
morphological phase contrast analysis
 
neurofilament proteins NFL
 
P2X ionotropic
 
P2Y metabotropic families
 
P2Y12 receptors
 
P2Y4 protein
 
P2Y4 receptor
 
P2Y4 receptor participates
 
P2Y4 subtype
 
P2Y4-transfected SH-SY5Y cells
 
physiological pyrimidine agonist UTP
 
simultaneous presence
 
various P2 receptors
 
Western blot analysis